EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Linked-Color Imaging Detects More Colorectal Adenoma and Serrated Lesions: An International Randomized Controlled Trial

Sho Suzuki, Satimai Aniwan, Han-Mo Chiu, Kannikar Laohavichitra, Sakkarin Chirapongsathorn, Takeshi Yamamura, Chen-Ya Kuo, Naohisa Yoshida, Tiing Leong Ang, Takahito Takezawa, Rungsun Rerknimitr, Hideki Ishikawa und 2 weitere

Clinical Gastroenterology and Hepatology · 2023-06 · 21 (6) · 1493-1502.e4

DOI: 10.1016/j.cgh.2022.10.021 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-06. Verfasst von Sho Suzuki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, International University of Health and Welfare, School of Medicine, Chiba, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenoma, Polyps, Colonic Polyps. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Effects of linked-color imaging (LCI) on colorectal lesion detection and colonoscopy quality remain controversial. This study compared the detection rates of adenoma and other precursor lesions using LCI vs white-light imaging (WLI) during screening, diagnostic, and surveillance colonoscopies. METHODS: This randomized controlled trial was performed at 11 institutions in 4 Asian countries/regions. Patients with abdominal symptoms, a primary screening colonoscopy, positive fecal immunochemical test results, or undergoing postpolypectomy surveillance were recruited and randomly assigned in a 1:1 ratio to either the LCI or high-definition WLI group. The primary outcome was adenoma detection rate (ADR). Secondary outcomes were polyp detection rate, advanced ADR, sessile serrated lesion (SSL) detection rate, and the mean number of adenomas per colonoscopy. The recommended surveillance schedule distribution after trial colonoscopy was analyzed. RESULTS: Between November 2020 and January 2022, there were 3050 participants (LCI, n = 1527; WLI, n = 1523) recruited. The LCI group ADR was significantly higher than the WLI group ADR using intention-to-treat (58.7% vs 46.7%; P < .01) and per-protocol analyses (59.6% vs 46.4%; P < .01). The LCI group polyp detection rates (68.6% vs 59.5%; P < .01), SSL detection rates (4.8% vs 2.8%; P < .01), and adenomas per colonoscopy (1.48 vs 1.02; P < .01) also were significantly higher. However, the advanced ADR was not significantly different (13.2% vs 11.0%; P = .06). Significantly more patients in the LCI group had shorter recommended surveillance schedules than the WLI group (P < .01). CONCLUSIONS: Compared with WLI, LCI improved adenoma and other polyp detection rates, including SSLs, resulting in alteration of the recommended surveillance schedule after screening, diagnostic, and postpolypectomy surveillance colonoscopies. TRIAL REGISTRATION NUMBER: UMIN000042432 (https://www.umin.ac.jp/ctr/index.htm).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAdenomaPolypsColonic PolypsHumansColonoscopyDiagnostic Imaging

Stichwörter der Autor:innen

Adenoma Detection RateColorectal PolypLinked Color ImagingSessile Serrated Lesion

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, International University of Health and Welfare, School of Medicine, Chiba, Japan.
  • Center of Excellence in Endoscopy for Gastrointestinal Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Electronic address: satimai@gmail.com.
  • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Rajavithi Digestive Endoscopy Center, Rajavithi Hospital, Bangkok, Thailand.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
  • Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Zitieren

APA

Suzuki, S., Aniwan, S., Chiu, H. M., Laohavichitra, K., Chirapongsathorn, S., Yamamura, T., Kuo, C. Y., Yoshida, N., Ang, T. L., Takezawa, T., Rerknimitr, R., Ishikawa, H., Gotoda, T., & ATLAS Trial Group (2023). Linked-Color Imaging Detects More Colorectal Adenoma and Serrated Lesions: An International Randomized Controlled Trial. Clinical Gastroenterology and Hepatology, 21(6), 1493-1502.e4. https://doi.org/10.1016/j.cgh.2022.10.021

Vancouver

Suzuki S, Aniwan S, Chiu HM, Laohavichitra K, Chirapongsathorn S, Yamamura T, et al. Linked-Color Imaging Detects More Colorectal Adenoma and Serrated Lesions: An International Randomized Controlled Trial. Clinical Gastroenterology and Hepatology. 2023;21(6):1493-1502.e4. doi:10.1016/j.cgh.2022.10.021

BibTeX
@article{Suzuki2023,
  author = {Suzuki, Sho and Aniwan, Satimai and Chiu, Han-Mo and Laohavichitra, Kannikar and Chirapongsathorn, Sakkarin and Yamamura, Takeshi and Kuo, Chen-Ya and Yoshida, Naohisa and Ang, Tiing Leong and Takezawa, Takahito and Rerknimitr, Rungsun and Ishikawa, Hideki and Gotoda, Takuji and ATLAS Trial Group, ATLAS Trial Group},
  title = {Linked-Color Imaging Detects More Colorectal Adenoma and Serrated Lesions: An International Randomized Controlled Trial},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {6},
  pages = {1493--1502.e4},
  doi = {10.1016/j.cgh.2022.10.021}
}
Kostenlos starten →